RBOT — Vicarious Surgical Inc.
—
OTC ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1812173 ·
Last close
$0.16
Market Cap
$1.00M
52W High
$1.00
52W Low
$0.14
ADV30
68,506
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 0 | — | -7,502,000 | -7,329,000 | 12,586,000 | 1,407,000 | 9,016,000 |
| Dec 2025 | 0 | — | -10,199,000 | -10,515,000 | 19,581,000 | 2,569,000 | 9,740,000 |
| Sep 2025 | 0 | — | -11,503,000 | -11,058,000 | 29,347,000 | 3,164,000 | 15,259,000 |
| Jun 2025 | 0 | — | -13,519,000 | -13,215,000 | 40,890,000 | 3,910,000 | 17,827,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-39,633,000
Investing CF
$32,594,000
Financing CF
$5,590,000
CapEx
$-141,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-6.69
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$-253,446,000
Inventory
—
Receivables
—
ST Investments
$2,275,000
EBIT TTM
$-42,723,000
Pretax Income TTM
$-42,117,000
Interest Exp TTM
$0
Analysts
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 0 | -50,968,000 | -50,182,000 | 19,581,000 | 9,740,000 | — | -45,076,000 |
| Dec 2024 | 0 | -66,555,000 | -63,223,000 | 67,719,000 | 21,021,000 | — | -49,956,000 |
| Dec 2023 | 0 | -80,666,000 | -71,071,000 | 119,864,000 | 21,895,000 | — | -62,305,000 |
| Dec 2022 | 0 | -80,078,000 | 5,157,000 | 140,291,000 | 29,246,000 | — | -61,211,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-2.17
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| LYRA | Lyra Therapeutics, Inc. | $958.3K | $0.54 | — |
| LGMK | LogicMark, Inc. | $899.8K | $1.00 | — |
| PFSA | Profusa, Inc. | $1.12M | $2.12 | — |
| YBGJ | Yubo International Biotech Ltd | $1.12M | $0.01 | — |
| ESMC | ESCALON MEDICAL CORP | $1.41M | $0.19 | — |
News headlines (Yahoo Finance, 1h cache)
Vicarious Surgical Demonstrates Sustained System Performance and Complex Hernia Procedure Workflows in Pre-Clinical Setting
2026-05-13 13:00 · Yahoo
Vicarious Surgical Reports First Quarter 2026 Financial Results
2026-04-30 12:30 · Yahoo
Vicarious Surgical Completes Integrated Benchtop Testing of Full Surgical Instrument Suite for Ventral Hernia Repair
2026-03-30 20:15 · Yahoo
Vicarious Surgical Begins Quotation on the OTCQB as Part of Strategic Path Toward Potential Nasdaq Listing
2026-03-25 20:15 · Yahoo
Vicarious Surgical receives NYSE delisting notice
2026-03-04 15:24 · Yahoo
Vicarious inks software partnership as it streamlines operations
2026-01-06 10:07 · Yahoo
RBOT Enters Strategic Software Partnership to Streamline Development
2025-12-30 15:42 · Yahoo
Vicarious says it will outsource some robot development functions
2025-11-14 11:09 · Yahoo
Vicarious Surgical Inc (RBOT) Q3 2025 Earnings Call Highlights: Strategic Cost Management and ...
2025-11-13 05:02 · Yahoo
Vicarious Surgical delays robot clinical timeline
2025-08-14 11:42 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.